These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 16136990)

  • 21. Characterization of hydroxyl radical modified GAD65: a potential autoantigen in type 1 diabetes.
    Khan MW; Sherwani S; Khan WA; Ali R
    Autoimmunity; 2009 Feb; 42(2):150-8. PubMed ID: 19085183
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Diabetes mellitus--differential diagnosis].
    Hummel M; Füchtenbusch M
    MMW Fortschr Med; 2006 May; 148(20):47-50. PubMed ID: 16805191
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autoimmunity in "type 2" and gestational diabetes mellitus.
    Fitz-Patrick D
    Endocr Pract; 2001; 7(5):407-8. PubMed ID: 11585380
    [No Abstract]   [Full Text] [Related]  

  • 24. Interferon-alpha and development of type 1 diabetes: a case without insulin resistance.
    Tohda G; Oida K; Higashi S; Hayashi T; Miyamori I
    Diabetes Care; 1998 Oct; 21(10):1774. PubMed ID: 9773746
    [No Abstract]   [Full Text] [Related]  

  • 25. Autoantibodies in Type 1 diabetes.
    Schmidt KD; Valeri C; Leslie RD
    Clin Chim Acta; 2005 Apr; 354(1-2):35-40. PubMed ID: 15748597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High titer of autoantibodies to GAD identifies a specific phenotype of adult-onset autoimmune diabetes.
    Buzzetti R; Di Pietro S; Giaccari A; Petrone A; Locatelli M; Suraci C; Capizzi M; Arpi ML; Bazzigaluppi E; Dotta F; Bosi E;
    Diabetes Care; 2007 Apr; 30(4):932-8. PubMed ID: 17392553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pancreatic autoantibodies in Italian patients with newly diagnosed type 1 diabetes mellitus over the age of 20 years.
    Betterle C; Lazzarotto F; Fusari A; Zanchetta R; Benedini S; Pedini B; Moscon A; Presotto F
    Acta Diabetol; 2006 Nov; 43(3):79-83. PubMed ID: 17143785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and biochemical characteristics of nonobese type 2 diabetic patients with glutamic acid decarboxylase antibody in Korea.
    Kim CS; Nam JH; Nam JS; Park JS; Kang ES; Ahn CW; Cha BS; Lim SK; Kim KR; Lee HC; Huh KB
    Metabolism; 2006 Aug; 55(8):1107-12. PubMed ID: 16839848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Latent autoimmune diabetes in adults].
    Maioli M; Puddu L; Pes GM
    Clin Ter; 2006; 157(1):69-78. PubMed ID: 16669554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Latent autoimmune diabetes in adults: a guide for the perplexed.
    Gale EA
    Diabetologia; 2005 Nov; 48(11):2195-9. PubMed ID: 16193287
    [No Abstract]   [Full Text] [Related]  

  • 31. T-cell responses to islet antigens improves detection of autoimmune diabetes and identifies patients with more severe beta-cell lesions in phenotypic type 2 diabetes.
    Goel A; Chiu H; Felton J; Palmer JP; Brooks-Worrell B
    Diabetes; 2007 Aug; 56(8):2110-5. PubMed ID: 17473222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High titer of autoantibodies to GAD identifies a specific phenotype of adult-onset autoimmune diabetes: response to Buzzetti et al.
    Kobayashi T; Tanaka S; Shimada A; Maruyama T
    Diabetes Care; 2007 Nov; 30(11):e126; author reply e127. PubMed ID: 17965310
    [No Abstract]   [Full Text] [Related]  

  • 33. [Diagnostic value of serum islet autoantibody in hepatogenic diabetes mellitus].
    Zhang L; Shi YL; Hong WX; Jia WD; Li LH
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jul; 26(7):1034-6. PubMed ID: 16864107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fasting c-peptide and insulin-like growth factor-binding protein-1 levels help to distinguish childhood type 1 and type 2 diabetes at diagnosis.
    Katz LE; Jawad AF; Ganesh J; Abraham M; Murphy K; Lipman TH
    Pediatr Diabetes; 2007 Apr; 8(2):53-9. PubMed ID: 17448127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glutamic acid decarboxylase antibodies in idiopathic generalized epilepsy and type 1 diabetes.
    Striano P; Perruolo G; Errichiello L; Formisano P; Beguinot F; Zara F; Striano S
    Ann Neurol; 2008 Jan; 63(1):127-8. PubMed ID: 17167787
    [No Abstract]   [Full Text] [Related]  

  • 36. Prevalence and clinical characteristics of insulin-treated, anti-GAD-positive, type 2 diabetic subjects in an outpatient clinical department of a Dutch teaching hospital.
    Römkens TE; Kusters GC; Netea MG; Netten PM
    Neth J Med; 2006 Apr; 64(4):114-8. PubMed ID: 16609158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical and immunological profile of newly diagnosed non-obese adult patients with diabetes].
    Szelachowska M; Szepietowska B; Popławska A; Jakubczyk D; Górska M; Kinalska I
    Przegl Lek; 2002; 59(11):885-7. PubMed ID: 12715714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Persisting antibodies to glutamic acid decarboxylase in type 1 (insulin-dependent) diabetes mellitus are not associated with neuropathy.
    Tuomi T; Zimmet PZ; Rowley MJ; Serjeantson SW; Mackay IR
    Diabetologia; 1993 Jul; 36(7):685. PubMed ID: 8359590
    [No Abstract]   [Full Text] [Related]  

  • 39. Seroconversion of GAD antibody in unclassified diabetes with long duration of disease.
    Shigihara T; Shimada A; Saisho Y; Kawai T; Maruyama H; Saruta T
    Diabetes Care; 2004 Jul; 27(7):1836-7. PubMed ID: 15220276
    [No Abstract]   [Full Text] [Related]  

  • 40. Chronic complications and mortality in community-based patients with latent autoimmune diabetes in adults: the Fremantle Diabetes Study.
    Myhill P; Davis WA; Bruce DG; Mackay IR; Zimmet P; Davis TM
    Diabet Med; 2008 Oct; 25(10):1245-50. PubMed ID: 19046207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.